This is a framework agreement for the supply of laboratory reagents for blood analysis and non-chemical single-use medical supplies, as well as hematological consumables, divided into 5 lots. The contracting authority will respond clearly and completely to all qualification requests and additional i
Tender closed on 22 Sept 2025. Awaiting award.
Mostly framework call-offs rather than head-to-head competition.
In healthcare medical, EMERGENCY HOSPITAL OF THE MINISTRY OF INTERIOR PROF DR DIMITRIE GEROTA BUCHAREST has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
The contracting authority is seeking to establish public procurement contracts for the purchase of medical equipment as part of the AI-Assisted Robotic and Laparoscopic Surgery Project - Phase I, specifically for the Pathology Laboratory. The required equipment includes: Lot 1: A fully automated sys
The contracting authority is seeking to establish framework agreements for the procurement of pharmaceuticals as detailed in Annex 1 of the specifications document. The deadline for the contracting authority to respond clearly and completely to all qualification requests and additional information i
The contracting authority intends to establish framework agreements for the procurement of food products to ensure the nourishment of patients at the "Prof. Dr. Dimitrie Gerota" Emergency Hospital and S.R.F.M.B. Bușteni. This includes 14 lots, with specific technical specifications attached to the t
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
